Glanbia plc (GLAPF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Glanbia plc (GLAPF) with AI Score 48/100 (Weak). Glanbia plc is a global nutrition company based in Ireland, focusing on sports nutrition, lifestyle nutrition, and nutritional ingredients. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 15, 2026Glanbia plc (GLAPF) Consumer Business Overview
Glanbia plc is a global nutrition company specializing in sports and lifestyle nutrition products, as well as dairy and non-dairy ingredients. With a diverse portfolio of brands and a wide distribution network, Glanbia serves specialty retail, online, gym, and mass-market channels, positioning itself in the competitive packaged foods sector.
Investment Thesis
Glanbia plc presents a compelling investment case based on its strong market position in the growing nutrition industry. With a market capitalization of $4.80 billion and a beta of 0.47, Glanbia exhibits relatively low volatility. The company's diversified product portfolio, including sports nutrition and lifestyle nutrition products, caters to a broad consumer base. A gross margin of 26.9% and a profit margin of 4.6% indicate solid profitability, while a ROE of 9.2% reflects efficient capital utilization. Growth catalysts include expanding its online presence and distribution networks to tap into the growing e-commerce market for nutrition products. Potential risks include fluctuations in raw material costs and increasing competition in the sports nutrition market. Glanbia's ability to innovate and adapt to changing consumer preferences will be crucial for maintaining its competitive edge.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $4.80B indicates a substantial presence in the nutrition industry.
- Gross Margin of 26.9% reflects Glanbia's ability to manage production costs and maintain profitability.
- Profit Margin of 4.6% demonstrates the company's efficiency in converting revenue into profit.
- ROE of 9.2% signifies effective utilization of shareholder equity to generate profits.
- Debt-to-Equity Ratio of 58.41 indicates a moderate level of financial leverage.
Competitors & Peers
Strengths
- Strong brand portfolio with established brands like Optimum Nutrition and BSN.
- Diversified product portfolio across sports nutrition, lifestyle nutrition, and ingredients.
- Extensive distribution network reaching various channels and geographies.
- Expertise in developing and manufacturing high-quality nutritional ingredients.
Weaknesses
- Dependence on key brands, making it vulnerable to changes in consumer preferences.
- Exposure to fluctuations in raw material costs, impacting profitability.
- Limited presence in emerging markets compared to larger competitors.
- Relatively low profit margin compared to some industry peers.
Catalysts
- Ongoing: Expansion of online sales channels to capitalize on the growing e-commerce trend.
- Ongoing: Product innovation in plant-based nutrition to meet the increasing demand for vegan products.
- Ongoing: Geographic expansion into emerging markets with growing health awareness.
- Upcoming: Potential strategic acquisitions of complementary brands to expand product portfolio and market reach.
- Ongoing: Development of personalized nutrition solutions to cater to individual needs and preferences.
Risks
- Ongoing: Increasing competition in the sports nutrition market from established and emerging players.
- Ongoing: Changing consumer preferences and trends, requiring continuous innovation and adaptation.
- Potential: Regulatory changes and health claims restrictions impacting product marketing and sales.
- Potential: Economic downturns affecting consumer spending on discretionary nutrition products.
- Ongoing: Fluctuations in raw material costs impacting profitability.
Growth Opportunities
- Expansion of Online Sales Channels: Glanbia can capitalize on the growing e-commerce trend by expanding its online sales channels and partnerships with online retailers. The global e-commerce market for food and beverage is projected to reach $290 billion by 2027. By strengthening its online presence, Glanbia can reach a wider customer base and increase sales. This includes optimizing its website for mobile commerce and investing in digital marketing to drive traffic and conversions.
- Product Innovation in Plant-Based Nutrition: The demand for plant-based nutrition products is rapidly increasing, driven by health and environmental concerns. Glanbia can capitalize on this trend by developing and launching new plant-based protein powders, bars, and beverages. The global plant-based protein market is expected to reach $14.5 billion by 2025. Glanbia can leverage its expertise in ingredient technology and product development to create innovative and appealing plant-based products.
- Geographic Expansion into Emerging Markets: Emerging markets, such as Asia and Latin America, offer significant growth opportunities for Glanbia. These markets have a growing middle class and increasing awareness of health and wellness. Glanbia can expand its presence in these markets by establishing local distribution partnerships and tailoring its products to local tastes and preferences. The Asia-Pacific sports nutrition market is projected to grow at a CAGR of 8.5% from 2020 to 2027.
- Strategic Acquisitions of Complementary Brands: Glanbia can accelerate its growth by acquiring complementary brands in the sports nutrition and functional ingredients space. This can provide access to new markets, technologies, and customer segments. The company has a history of successful acquisitions and can leverage its expertise to identify and integrate attractive targets. Potential acquisition targets could include companies with strong brands in niche categories or those with innovative ingredient technologies.
- Development of Personalized Nutrition Solutions: Personalized nutrition is an emerging trend that involves tailoring nutrition recommendations and products to individual needs and preferences. Glanbia can develop personalized nutrition solutions by leveraging data analytics and technology. This could involve offering customized protein blends based on individual fitness goals and dietary requirements. The personalized nutrition market is expected to reach $16.7 billion by 2025. Glanbia can partner with technology companies and healthcare providers to develop and deliver personalized nutrition solutions.
Opportunities
- Expansion of online sales channels to capitalize on the growing e-commerce trend.
- Product innovation in plant-based nutrition to meet the increasing demand for vegan products.
- Geographic expansion into emerging markets with growing health awareness.
- Strategic acquisitions of complementary brands to expand product portfolio and market reach.
Threats
- Increasing competition in the sports nutrition market from established and emerging players.
- Changing consumer preferences and trends, requiring continuous innovation and adaptation.
- Regulatory changes and health claims restrictions impacting product marketing and sales.
- Economic downturns affecting consumer spending on discretionary nutrition products.
Competitive Advantages
- Strong Brand Portfolio: Glanbia owns well-known brands like Optimum Nutrition and BSN, which have strong brand recognition and customer loyalty.
- Diversified Product Portfolio: Glanbia offers a wide range of products across sports nutrition, lifestyle nutrition, and ingredients, reducing its reliance on any single product category.
- Extensive Distribution Network: Glanbia has a multi-channel distribution network that reaches a broad customer base across various geographies.
- Ingredient Technology Expertise: Glanbia has expertise in developing and manufacturing high-quality nutritional and functional ingredients.
About GLAPF
Founded in 1964 and headquartered in Kilkenny, Ireland, Glanbia plc has evolved into a leading global nutrition company. Initially rooted in dairy processing, Glanbia has strategically expanded its portfolio to include sports nutrition, lifestyle nutrition, and nutritional ingredients. The company's core business revolves around developing, manufacturing, and marketing a range of products, including protein powders, ready-to-eat bars, beverages, and vitamin and mineral premixes. These products cater to athletes, fitness enthusiasts, and health-conscious consumers worldwide. Glanbia's product offerings are marketed under well-established brands such as Optimum Nutrition, BSN, Isopure, Nutramino, think!, and Amazing Grass. The company distributes its products through a diverse network of channels, including specialty retail stores, online retailers, gyms, and food, drug, mass, and club stores. This multi-channel approach allows Glanbia to reach a broad customer base and adapt to changing consumer preferences. Beyond its branded consumer products, Glanbia also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients to other food and beverage companies. This business segment provides a stable revenue stream and complements Glanbia's consumer-facing operations. The company also engages in financing, property and land dealing, property leasing, business services, management solutions, and bioactive solutions, diversifying its business interests.
What They Do
- Develops and markets sports nutrition products like protein powders, bars, and ready-to-drink beverages.
- Offers lifestyle nutrition products catering to health-conscious consumers.
- Manufactures and sells dairy and non-dairy nutritional and functional ingredients.
- Provides vitamin and mineral premixes products for various applications.
- Sells its products through specialty retail, online, gym, and mass-market channels.
- Engages in financing, property, and business services.
Business Model
- Develops and manufactures sports and lifestyle nutrition products under its own brands.
- Sells nutritional and functional ingredients to other food and beverage companies.
- Distributes products through a multi-channel network, including retail, online, and wholesale channels.
- Generates revenue through product sales and service offerings.
Industry Context
Glanbia plc operates within the consumer defensive sector, specifically in the packaged foods industry. This sector is characterized by relatively stable demand, as consumers continue to purchase food products regardless of economic conditions. The global nutrition market is experiencing significant growth, driven by increasing health awareness and changing consumer lifestyles. Glanbia competes with other major players in the sports nutrition and functional ingredients space, including companies like Nestle and Unilever, as well as smaller, specialized brands. The industry is also influenced by trends such as plant-based nutrition and personalized nutrition, requiring companies to innovate and adapt to changing consumer preferences.
Key Customers
- Athletes and fitness enthusiasts seeking sports nutrition products.
- Health-conscious consumers looking for lifestyle nutrition products.
- Food and beverage companies requiring nutritional and functional ingredients.
- Retailers and distributors selling nutrition products to end consumers.
Financials
Chart & Info
Glanbia plc (GLAPF) stock price: Price data unavailable
Latest News
-
Glanbia PLC (GLAPF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Cost ...
Yahoo! Finance: GLAPF News · Feb 25, 2026
-
Weight Management Supplements Market Report 2026: A $15+ Billion Market by 2030 Featuring Leading Players - Nestle, Abbott Laboratories, GSK, Glanbia, Herbalife Nutrition, and Amway - Forecast to 2035
GlobeNewswire · Feb 20, 2026
-
Looking At The Narrative For Glanbia (ISE:GL9) After Subtle Shifts In Street Targets
Yahoo! Finance: GLAPF News · Feb 5, 2026
-
Stocks That Hit 52-Week Lows On Friday
· Aug 23, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GLAPF.
Price Targets
Wall Street price target analysis for GLAPF.
MoonshotScore
What does this score mean?
The MoonshotScore rates GLAPF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
Glanbia PLC (GLAPF) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Cost ...
Weight Management Supplements Market Report 2026: A $15+ Billion Market by 2030 Featuring Leading Players - Nestle, Abbott Laboratories, GSK, Glanbia, Herbalife Nutrition, and Amway - Forecast to 2035
Looking At The Narrative For Glanbia (ISE:GL9) After Subtle Shifts In Street Targets
Stocks That Hit 52-Week Lows On Friday
GLAPF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Glanbia plc (GLAPF) may not meet the minimum financial or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may not be subject to the same level of scrutiny as those listed on major exchanges like the NYSE or NASDAQ. This tier is typically reserved for companies with limited operating history, distressed financials, or those that choose not to comply with higher listing standards. Investors should exercise caution and conduct thorough due diligence before investing in companies on the OTC Other tier.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Disclosure: Lack of readily available financial information increases investment risk.
- Low Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Price Volatility: Potential for significant price swings due to limited trading activity.
- Regulatory Scrutiny: Increased risk of regulatory action due to non-compliance with reporting requirements.
- Counterparty Risk: Higher risk of dealing with unreliable or fraudulent counterparties.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Analyze the company's capital structure and debt levels.
- Monitor trading volume and price volatility.
- Consult with a qualified financial advisor.
- Established Operating History: Glanbia plc has been in operation since 1964.
- Recognizable Brands: The company owns well-known brands like Optimum Nutrition and BSN.
- Global Presence: Glanbia operates in multiple countries and regions.
- Employee Count: The company employs a significant number of people (4,963).
- Market Capitalization: Glanbia has a substantial market capitalization ($4.80B).
GLAPF Consumer Defensive Stock FAQ
What does Glanbia plc do?
Glanbia plc is a global nutrition company that develops, manufactures, and markets a range of sports nutrition, lifestyle nutrition, and nutritional ingredients. Its sports nutrition products, marketed under brands like Optimum Nutrition and BSN, include protein powders, bars, and ready-to-drink beverages targeted at athletes and fitness enthusiasts. The company also produces lifestyle nutrition products for health-conscious consumers and supplies nutritional ingredients to other food and beverage companies. Glanbia distributes its products through a multi-channel network, including retail stores, online retailers, and wholesale distributors.
What do analysts say about GLAPF stock?
Analyst consensus on GLAPF stock is currently unavailable. Key valuation metrics to consider include the company's price-to-earnings ratio, price-to-sales ratio, and enterprise value-to-EBITDA ratio, compared to its industry peers. Growth considerations include the company's ability to expand its online sales channels, innovate in plant-based nutrition, and penetrate emerging markets. Investors should also monitor the company's financial performance, including revenue growth, profit margins, and cash flow generation. It is important to note that this is not investment advice, and investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions.
What are the main risks for GLAPF?
Glanbia plc faces several risks, including increasing competition in the sports nutrition market, changing consumer preferences and trends, and potential regulatory changes and health claims restrictions. The company is also exposed to fluctuations in raw material costs, which can impact its profitability. Additionally, economic downturns could affect consumer spending on discretionary nutrition products, reducing demand for Glanbia's products. The company's reliance on key brands also poses a risk, as changes in consumer preferences or negative publicity could impact sales. Investors should carefully consider these risks before investing in GLAPF.
What are the key factors to evaluate for GLAPF?
Glanbia plc (GLAPF) currently holds an AI score of 48/100, indicating low score. Key strength: Strong brand portfolio with established brands like Optimum Nutrition and BSN.. Primary risk to monitor: Ongoing: Increasing competition in the sports nutrition market from established and emerging players.. This is not financial advice.
How frequently does GLAPF data refresh on this page?
GLAPF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GLAPF's recent stock price performance?
Recent price movement in Glanbia plc (GLAPF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Strong brand portfolio with established brands like Optimum Nutrition and BSN.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GLAPF overvalued or undervalued right now?
Determining whether Glanbia plc (GLAPF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GLAPF?
Before investing in Glanbia plc (GLAPF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- Analyst consensus data is not currently available.